PrEP SMART Phase I Trial

Completed · Phase 1

Conditions studied: At Risk for HIV

In brief

The goal of this Phase I study is to conduct a proof-of-concept trial of a contingency management (CM) targeting adherence to oral HIV antiretroviral pre-exposure prophylaxis (PrEP) administered via a smartphone-based medication adherence platform (PrEP SMART, "the app").

Key facts

Study ID

NCT02895893

Run by

Duke University

People needed

12

Starts

2016-07-01

Expected to finish

2017-05-04

Last updated by the study team

2017-05-22

Who can join

Age: 18 and older, up to 30. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Male
• 18-30 years of age
• Self-report having sex with men in the past 6 months
• Currently prescribed PrEP (Truvada) for HIV prevention
• English-speaking
• Participant has an Android or iOS smartphone

You may not qualify if…

• History of chronic/significant medical or psychiatric condition that will interfere with study participation
• Unable to attend sessions

Where it is running

• Duke University Medical Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.